Happy 25th birthday, Bet v 1! by Erika Jensen-Jarolim
journal
Jensen-Jarolim World Allergy Organization Journal 2014, 7:14
http://www.waojournal.org/content/7/1/14EDITORIAL Open AccessHappy 25th birthday, Bet v 1!
Erika Jensen-Jarolim1,2As the deputy editor of WAOJ I am concentrating on
basic science, but with continuous focus on the clinical
relevance of submitted studies for our allergic and atopic
patients. The questions that follow me are 1.) “What
makes an allergen an allergen?” and 2.) “Why do humans
and other mammalians form IgE?”.
Within the period which I personally can oversee in
the allergy field, i.e. roughly 25 years, tremendous efforts
and luckily also progress have been made in understand-
ing allergy mechanisms, from the Th1-Th2 [1] paradigm
to Tregs [2], from immunoblot [3] and molecular clo-
ning of allergens [4-6] to cloning of IgE receptors [7,8],
the cognition of their function in antigen presentation
[9,10] and transgenic models imitating human disease
[11]. This time span covered the transition from allergen
extracts to molecular allergology. The latter is perhaps
the most significant change that we experienced, which
so far at least resulted in the improved diagnosis of aller-
gies [12]. We may today decide between molecules caus-
ing less or more severe symptoms and between allergens
that are associated with the different clinical pictures.
This means true help for optimal patient care.
For instance, Fel d 1 from cat and Can f 1 from dog
are significantly associated with asthma and may be
regarded as biomarkers for it [13]. Not only molecules,
but also carbohydrate decorations like alpha-Gal may
cause severe symptoms – and be associated not only
with pet and insect sensitization, but also with severe food
allergy, or –amazingly, with hypersensitivity reactions to
biological agents when expressed in insect vectors [14].
From the first analyses of allergen extract we have
started to experience that not all, but a limited number
of compounds act as allergens, i.e. form and bind IgE
[15]. Why is that so? At least for some molecules re-
search has so far brought out the interesting information
that sensitization may have to do with the function of
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unless otherwise stated.For instance, Der p 1 from house dust mite, which
enzymatically breaks up the bronchial and skin barrier,
thereby promotes its own entrance [16]. Hence we un-
derstand why for some allergens the risk for sensitization
is higher the higher the exposure, even better in atopic
predisposition. This approves our empiric observation
that allergen reduction in the environment, or better
avoidance, is an important practical measure. In fact, we
thereby also control their non-specific action. Some al-
lergens are inhibitors of enzymes, and one might specu-
late that they inhibit the gastrointestinal digestion and
may persist during the transit due to their own inhibi-
tory function. For instance, Ara h 2 is a trypsin inhibitor
and food processing such as roasting may even enhance
these functions [17].
One of the most chased allergen, however, is Bet v 1.
Here, the situation is even more extreme: Bet v 1 is the
single major allergen from birch pollen. I am proud to
say that Vienna is the cradle of one of the most im-
portant and fascinating molecules in allergy: Right from
the beginning Bet v 1 was classified as a pathogenesis-
related molecule being overexpressed in various stress
conditions of the plant [4]. Since its cloning in 1989, its
T-cell and B-cell epitopes were defined [18,19] and the
Bet v 1 structure was revealed by X-ray crystallogra-
phy as a 17 kDa globular molecule with a pocket inside
[20]. We understand that the birch pollen related oral al-
lergy syndrome is due to molecular homology causing
IgE-crossreactivity among the Bet v 1 homologs in many
plant species which we eat [21]; the fact that Bet v 1 and
most of its food homologs are devoid of intramolecular
disulfide bridges explains their lability in the gastroin-
testinal transit [22] and makes them “non-sensitizing eli-
citors” of food allergy. Whether multiple epitopes are
needed for crosslinking in the effector phase or whether
dimer formation of Bet v 1 is needed for its IgE cross
linking capacity, is a matter of debate [23,24]. In search
for the ligand of the secret intramolecular pocket of Bet v
1, researchers recently proposed quercetin-3-O-sophoro-
side, to make the fit [25]. However, the basal question
remains: why is exclusively Bet v 1 the allergen out of
the plethora of birch molecules in the extract? Whyal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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Figure 1 The Betv1-Fe-quercetin complex. The Birthday-molecule
Bet v 1 (silver), carrying a siderophore molecule (quercetin) in its
pocket binding one iron molecule Fe3+ (white ball). Bet v 1 acts as
allergen when its pocket is devoid of iron. Cartoon kindly created by
Prof. Luis F. Pacios, Unidad de Química y Bioquímica, Departamento
de Biotecnología, E.T.S.I. Montes, UPM, 28040 Madrid, Spain.
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of a significant Th2 bias and isotype switch to specific
IgE production?
We have the answer today. Quercetin is a siderophore
and as such is able to bind iron similarly to catechols.
More importantly, the siderophore-iron complex is able
to bind with an outstanding binding affinity to lipoca-
lin proteins [26]. By a revolutionary approach, Bet v 1
could in fact be classified as a lipocalin-like protein [27]
(Figure 1). Most importantly, Bet v 1 in the absence of
Fe3+ manipulates Th-cells and skews the immune res-
ponse towards Th2 whereas the presence of iron abolishes
a Th2 response. This molecular and functional under-
standing contributes another stone in the allergy puzzle.
Happy 25th birthday, Bet v 1!
So, why is it important to bring more of molecular al-
lergy into WAOJ? Using this journal as a global informa-
tion exchange platform, we may sense system errors in
our changing world, in our environment or nutrition,
which are able to directly affect the immune balance.
In fact, we should in a concerted action systematically
search for system errors in our societies, which contrib-
ute to allergy and atopy in humans and their pets; errors
that have been introduced by establishment or fall down
of borders, by introduction of new technologies in traffic
or food production. WAOJ should be a platform special-
ized for collecting data from all over the world elucidatinggeographical differences in molecular sensitization pat-
terns between countries, south and north, or even bet-
ween neighboring villages.
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